FDA Announces New Quality Oversight Webpage

[03/15/2024] Today, FDA is announcing a new webpage to showcase how the agency uses one of its oversight tools, inspections, to help ensure drug safety and quality.FDA monitors drugs on the market to help make certain they continue to meet the agency’s standards for...

CDER Statement

[3-11-2024] Today, FDA issued a revised draft guidance, Early Alzheimer’s Disease: Developing Drugs for Treatment Guidance for Industry. Once finalized, the guidance will provide recommendations to help drug companies developing medicines to treat patients with early...

CDER Statement

[03/13/2024] EUA-labeled Paxlovid is no longer authorized for emergency use, regardless of the labeled or extended expiration date. For both NDA-approved and EUA-authorized uses, only NDA-labeled Paxlovid may be dispensed. Today’s revision to the Paxlovid EUA...